Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Terazosin Hydrochloride Tablets 1 mg
  Indications :
 

Benign prostate hyperplasia (BPH)

Management of mild to moderate hypertension

BPH with concomitant cardiovascular diseases

Expulsion of lower ureteral stones

   
  Dosage :
  Adults : Initial dose should not exceed 1 mg in any indication. If drug is discontinued for long duration, consider beginning with initial dose and retitrate as needed

Benign prostatic hyperplasia :
Initial Dose :
1 mg at bedtime , gradually increasing the subsequent doses to 2 mg , 5 mg or 10 mg once daily up to a maximum of 20 mg/ day if no response after 4-6 weeks of 10 mg/day.

Usual dose : 5-10 mg once daily.

Hypertension :
Initial Dose :
1 mg at bedtime; slowly increase dose to achieve desired blood pressure response, up to maximum of 20 mg/day.

Usual dose : 2-10 mg once daily
Dosage reduction may be needed when adding a diuretic or other antihypertensive agent; dosage may be given on a twice daily regimen if response is diminished at 24 hours and hypotensive is observed at 2-4 hours following a dose

Dosage Adjustment :

Renal Impairment : Modification of dosage in such patients generally does not appear to be necessary.

Hepatic Impairment : Not well studied, administer with caution.
   
  Packing : 10 Strips of 10 Tablets
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.